Literature DB >> 31269263

The physiological role of α-synuclein and its relationship to Parkinson's Disease.

David Sulzer1, Robert H Edwards2.   

Abstract

The protein α-synuclein has a central role in the pathogenesis of Parkinson's disease (PD). In this review, we discuss recent results concerning its primary function, which appears to be on cell membranes. The pre-synaptic location of synuclein has suggested a role in neurotransmitter release and it apparently associates with synaptic vesicles because of their high curvature. Indeed, synuclein over-expression inhibits synaptic vesicle exocytosis. However, loss of synuclein has not yet been shown to have a major effect on synaptic transmission. Consistent with work showing that synuclein can promote as well as sense membrane curvature, recent analysis of synuclein triple knockout mice now shows that synuclein accelerates dilation of the exocytic fusion pore. This form of regulation affects primarily the release of slowly discharged lumenal cargo such as neural peptides, but presumably also contributes to maintenance of the release site. This article is part of the Special Issue "Synuclein".
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  Lewy pathology; Parkinson's disease; fusion pore; regulated exocytosis; synaptic vesicle; synuclein

Mesh:

Substances:

Year:  2019        PMID: 31269263      PMCID: PMC6707892          DOI: 10.1111/jnc.14810

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  156 in total

1.  Rapid reuse of readily releasable pool vesicles at hippocampal synapses.

Authors:  J L Pyle; E T Kavalali; E S Piedras-Rentería; R W Tsien
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

2.  Synapsin dispersion and reclustering during synaptic activity.

Authors:  P Chi; P Greengard; T A Ryan
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

3.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

4.  A phospho-switch controls the dynamic association of synapsins with synaptic vesicles.

Authors:  M Hosaka; R E Hammer; T C Südhof
Journal:  Neuron       Date:  1999-10       Impact factor: 17.173

5.  Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury.

Authors:  N G Kholodilov; M Neystat; T F Oo; S E Lo; K E Larsen; D Sulzer; R E Burke
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

6.  Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.

Authors:  Nelson B Cole; Diane D Murphy; Theresa Grider; Susan Rueter; Dawn Brasaemle; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

7.  Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members.

Authors:  S Heber; J Herms; V Gajic; J Hainfellner; A Aguzzi; T Rülicke; H von Kretzschmar; C von Koch; S Sisodia; P Tremml; H P Lipp; D P Wolfer; U Müller
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

8.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

Authors:  E Masliah; E Rockenstein; I Veinbergs; M Mallory; M Hashimoto; A Takeda; Y Sagara; A Sisk; L Mucke
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

9.  Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form.

Authors:  He-Jin Lee; Chan Choi; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

10.  Conformational properties of alpha-synuclein in its free and lipid-associated states.

Authors:  D Eliezer; E Kutluay; R Bussell; G Browne
Journal:  J Mol Biol       Date:  2001-04-06       Impact factor: 5.469

View more
  69 in total

1.  α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.

Authors:  Dorit Trudler; Sara Sanz-Blasco; Yvonne S Eisele; Swagata Ghatak; Karthik Bodhinathan; Mohd Waseem Akhtar; William P Lynch; Juan C Piña-Crespo; Maria Talantova; Jeffery W Kelly; Stuart A Lipton
Journal:  J Neurosci       Date:  2021-01-22       Impact factor: 6.167

Review 2.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

Review 3.  Heterogeneity of dopamine release sites in health and degeneration.

Authors:  Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2019-11-05       Impact factor: 5.996

4.  Disentangling aggregation-prone proteins: a new method for isolating α-synuclein species: An Editorial Highlight for "A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research" on page 103.

Authors:  Michael R Nichols
Journal:  J Neurochem       Date:  2020-02-10       Impact factor: 5.372

5.  α-synuclein and phosphoinositide-binding proteins: α-synuclein inhibits the association of PX- but not FYVE-containing proteins with vesicles in vivo.

Authors:  Santhanasabapathy Rajasekaran; Dhaval Patel; Stephan N Witt
Journal:  Biochem Biophys Res Commun       Date:  2022-03-04       Impact factor: 3.575

6.  [Regulatory mechanism of interferon regulatory factor 1 by α-synuclein in mouse Parkinson's disease model].

Authors:  F Mu; X Chen; X DU; Q Jiao; M Bi; H Jiang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

Review 7.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

8.  Insights into the molecular mechanism of amyloid filament formation: Segmental folding of α-synuclein on lipid membranes.

Authors:  Leif Antonschmidt; Rıza Dervişoğlu; Vrinda Sant; Kumar Tekwani Movellan; Ingo Mey; Dietmar Riedel; Claudia Steinem; Stefan Becker; Loren B Andreas; Christian Griesinger
Journal:  Sci Adv       Date:  2021-05-14       Impact factor: 14.136

9.  Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.

Authors:  Nelson Ferreira; Hjalte Gram; Zachary A Sorrentino; Emil Gregersen; Sissel Ida Schmidt; Lasse Reimer; Cristine Betzer; Clara Perez-Gozalbo; Marjo Beltoja; Madhu Nagaraj; Jie Wang; Jan S Nowak; Mingdong Dong; Katarina Willén; Ersoy Cholak; Kaare Bjerregaard-Andersen; Nicolas Mendez; Prakruti Rabadia; Mohammad Shahnawaz; Claudio Soto; Daniel E Otzen; Ümit Akbey; Morten Meyer; Benoit I Giasson; Marina Romero-Ramos; Poul Henning Jensen
Journal:  Acta Neuropathol       Date:  2021-05-12       Impact factor: 17.088

10.  Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: insights into Parkinson's disease.

Authors:  Susan M L Banks; Audrey T Medeiros; Rui Sousa; Eileen M Lafer; Jennifer R Morgan
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.